Cypherpunk Technologies has appointed Amanda Fabiano to its Board of Directors, bringing extensive experience in digital asset mining. Her addition aligns with the company's ambitious privacy technology goals.

Cypherpunk Technologies Inc. proudly announces the launch of Cypherpunk Mining, establishing itself as the world's largest Zcash mining fleet, with significant implications for investors.

Leap Therapeutics has announced significant findings from the DeFianCe study, revealing the potential of sirexatamab as a treatment for colorectal cancer, particularly benefiting patients with high DKK1 levels.

Cypherpunk Technologies Inc. reveals impressive financial results for 2025, with key investments and advancements in privacy technology and cancer treatment.

Cypherpunk Technologies has recently ramped up its Zcash holdings to over 290,000 ZEC, emphasizing its commitment to privacy technology and investment.

Purcell & Lefkowitz LLP has launched a shareholder investigation into Cypherpunk Technologies Inc. to determine potential breaches by the company's directors.

Cypherpunk Technologies Inc., formerly Leap Therapeutics, has revealed its Q3 2025 financial results, showcasing a strategic pivot towards Zcash development and digital asset acquisition.